You are here

Eribulin

Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends

Bloomberg

Tue, 11/16/10 - 11:57 am

Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer

Bloomberg

Mon, 11/15/10 - 06:26 pm

Eisai’s Breast Cancer Drug Gets Priority Review

Bloomberg

Wed, 06/2/10 - 08:24 am

Eisai Seeks Approval for Breast Cancer Drug Globally

Bloomberg

Wed, 03/31/10 - 08:09 am

Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival

PR NewsWire

Sat, 10/31/09 - 11:44 am